| Name: | Mometasone Furoate Impurity N |
| Catalogue No. | VL4080011 |
| CAS No. | 352315-75-4 |
| Molecular Formula | C₂₃H₃₁ClO₇S |
| Molecular Weight | 487.01 |
| Status | In-stock |
| IUPAC Name | 11β,16α)-9-Chloro-11,17-dihydroxy-16-methyl-21-[(methylsulfonyl)oxy]pregna-1,4-diene-3,20-dione |
| Synonyms | Mometasone Furoate Impurity N Mometasone EP Impurity N |
| Description | Mometasone Furoate Impurity N (CAS No: 352315-75-4) or Mometasone EP Impurity N is an impurity present in the synthesis of mometasone which is a corticosteroid with comparatively high in vitro potency. It is recommended for the prophylactic administration of mild to severe asthma in adults and adolescents. |
| References | Das, Saibal Kumar, et al. “Improvements in Corticosteroid 21-Acetoxy-17α-Hydroxy-16α-Methyl-Pregna-1,4,9(11)-Triene-3,20-Dione Synthesis and Its Use as Common Intermediate in the Synthesis of Some Impurities Related to Dexamethasone and Mometasone.” Steroids, vol. 148, Aug. 2019, pp. 47–55, https://doi.org/10.1016/j.steroids.2019.04.008. Sharpe, Miriam, and Blair Jarvis. “Inhaled Mometasone Furoate.” Drugs, vol. 61, no. 9, 2001, pp. 1325–50, https://doi.org/10.2165/00003495-200161090-00011. |
